Anthony S. Fiorino, Chief Executive Officer at BRAINSTORM CELL THERAPEUTICS INC. (BCLI), bought 18,000 shares at $0.28 ($5K) on 2014-09-15, disclosed to the SEC on 2014-09-16.
Open-market purchase of $5k BCLI by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.28 | 2,500 | $700 | 13.6% |
| 2 | $0.29 | 7,500 | $2K | 42.1% |
| 3 | $0.28 | 3,000 | $840 | 16.3% |
| 4 | $0.29 | 5,000 | $1K | 28.1% |
| Total | $0.29 avg | 18,000 | $5K | 100% |
| Filing → |
| BCLI | BUY | 2014-10-15 | $2K | — | Filing → |
| BCLI | BUY | 2014-09-19 | $3K | — | Filing → |